Company intelligence / Profile preview

Cysal

Münster, North Rhine-Westphalia, Germany
Ownership
Private
Employees
~5
Development stage
Other
01

Overview

Cysal is a German biotechnology company that focuses on the biotechnological production of dipeptides and amino acids using a proprietary fermentation platform. The company utilizes the biopolymer cyanophycin as a precursor to manufacture high-purity dipeptides, such as L-aspartyl-L-arginine, which offer improved solubility and stability. These products are primarily targeted at the cosmetics, animal nutrition, and pharmaceutical industries. By replacing traditional chemical synthesis with sustainable fermentation, Cysal provides an eco-friendly alternative for the production of complex nutritional and active ingredients. The company is a spin-off from the University of Münster and maintains strong ties to academic research in microbiology. Their lead products are already commercially available for use in high-end skincare formulations and specialized animal feed.

Therapeutic areas
DermatologyMetabolic Disorders
Modalities
Peptides
Industry
Non-Drug Biotech

Beyond the preview

Go deeper on Cysal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call